Manufactured by:ProteoGenix
Save 20%RUO

Mogamulizumab Biosimilar – Anti-CCR4, CD194 mAb – Research Grade

Mogamulizumab Biosimilar – Anti-CCR4, CD194 mAb – Research Grade from ProteoGenix; catalogue PX-TA1258; research use only.

SKU:
ABM134784-1
Manufacturer SKU
PX-TA1258
Product type
Primary Antibodies
TargetMogamulizumab Biosimilar – Anti-CCR4, CD194 mAb – Research Grade
ApplicationsELISA, WB, Flow Cytometry
Expression systemMammalian cells
Purity>85%

Manufacturer provenance

Manufactured by:
ProteoGenix
Sold by:
ABMIUM
Fulfilled from:
Manufacturer facility or confirmed fulfilment location

Know who made it. See the evidence. Buy through one marketplace.

Product description

General information on Anti-CCR4/CD194[Homo sapiens] (Mogamulizumab) Monoclonal Antibody

Mogamulizumab targets CC chemokine receptor 4 (CCR4) and is used for the treatment of Mycosis Fungoides (MF) and Sézary Syndrome (SS) which are subtypes of cutaneous T-cell lymphoma.

ProteoGenix catalogue number PX-TA1258. For research use only.

Target: Mogamulizumab Biosimilar – Anti-CCR4, CD194 mAb – Research Grade; Clonality: Monoclonal Antibody; Expression system: Mammalian cells; Purity: >85%; Buffer: PBS buffer PH7.5; Applications: ELISA, WB, Flow Cyt.

Available configurations: 50ug, 100ug, 1mg.

Download the manufacturer datasheet

Download the manufacturer safety data sheet (MSDS/SDS)

Key facts & specifications
Also known as
Mogamulizumab,AMG-761,KW-0761,CCR4, CD194,anti-CCR4, CD194
Clonality
Monoclonal
Isotype
IgG1-kappa
Source organism
CAS 1159266-37-1
Sequence
MNPTDIADTTLDESIYSNYYLYESIPKPCTKEGIKAFGELFLPPLYSLVFVFGLLGNSVVVLVLFKYKRLRSMTDVYLLNLAISDLLFVFSLPFWGYYAADQWVFGLGLCKMISWMYLVGFYSGIFFVMLMSIDRYLAIVHAVFSLRARTLTYGVITSLATWSVAVFASLPGFLFSTCYTERNHTYCKTKYSLNSTTWKVLSSLEINILGLVIPLGIMLFCYSMIIRTLQHCKNEKKNKAVKMIFAVVVLFLGFWTPYNIVLFLETLVELEVLQDCTFERYLDYAIQATETLAFVHCCLNPIIYFFLGEKFRKYILQLFKTCRGLFVLCQYCGLLQIYSADTPSSSYTQSTMDHDLHDAL
Technical note
For research use only. Not suitable for clinical or therapeutic use.
Validation & performance evidence
ABMIUM Validated™ ABMIUM Verified™ Expected performance Not suitable

Application validation

Evidence status by application and model.

TargetWBIHC-PIHC-FrIF/ICCFlow CytIPChIPELISA
Mogamulizumab Biosimilar – Anti-CCR4, CD194 mAb – Research Grade
Identifiers & database references
Manufacturer SKU
PX-TA1258
UniProt accession
P51679
Storage, stability & shipping
Storage conditions
store at -80°C
Shipped at
Blue ice (+4°C)
Compliance & documents
ISO certifications
ISO 9001:2023, ISO 14001: 2023
Datasheet
Open datasheet
Safety data sheet
Open SDS
Frequently asked questions
Who manufactured this product?

This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.

Can ABMIUM ship this product internationally?

ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.

Can I check suitability before ordering?

Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.

Is this product for clinical use?

Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.

ProteoGenix
£145.00£116.00